Published ā¢ loading... ā¢ Updated
Gan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma data
Summary by endpoints.news
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Gan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma data
Plus news about Sanofi, PharmaMar, Jazz, Rhythm Pharmaceuticals, Spyre and Zymeworks šØš³ Another obesity readout from China: Gan & Lee Pharmaceuticals, a China-based insulin specialist, announced topline Phase 3 results last ...
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
FactualityĀ
To view factuality data please Upgrade to Premium
